ArticleCureus2024
The Diagnostic Efficacy of Flexible Fiberoptic Laryngoscopy and Its Correlation With Histopathology in Different Benign Lesions of the Vocal Cord in a Tertiary Care Hospital: A Prospective Clinical Study.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Benign vocal cord lesions are diagnosed by clinical examination with usually an office-based laryngoscopy examination. The severity of voice impairment can be assessed by severity scores such as the Voice Handicap Index (VHI). These lesions are usually treated by conservative methods such as voice rest/restriction and voice therapy. A clinically benign-looking lesion does not always exclude the presence of malignancy. A mere clinical diagnosis of a benign vocal cord lesion is not complete, and hence, a confirmed diagnosis is made only after excision and histopathological examination (HPE) of the lesion. Aim This study was primarily aimed at knowing the prevalence, etiological factors, and clinical presentation of patients with benign vocal cord lesions, assessing the diagnostic potential of flexible fiberoptic laryngoscopy (FFL) in different benign lesions of the vocal cord and its correlation with histopathology, and studying the symptomatology and severity of symptoms in different benign vocal cord lesions using the Vocal Handicap Index-10. Method A prospective study of benign lesions of the vocal cord was conducted from January 2018 to June 2019 on 125 cases in a tertiary care hospital. All the benign lesions were clinically diagnosed with flexible fiberoptic laryngoscopy, and their findings were correlated with histopathology examination. Results Of the 125 patients, the overall prevalence of benign vocal cord lesions was higher in male patients (n = 88 (70.4%)) than in female patients (n = 37 (29.6%)). Voice abuse is the major risk factor for benign vocal cord lesions. The most common lesion identified by flexible fiberoptic laryngoscopic (FFL) examination is polyps (61%), followed by nodules (14%) and keratosis (13%). On the correlation of clinical diagnosis with histopathological examination, the diagnostic accuracy of FFL is 51.8% for nodules, 44.4% for polyps, 35.5% for keratosis, and 75% for granulomas. The diagnostic accuracy of FFL examination in diagnosing truly benign lesions is 94.9%. Conclusion Benign vocal cord lesions are one of the common cases seen in ENT practice. Voice abuse was the predominant causative factor for all these lesions. In our study, vocal polyp was the most common lesion by clinical examination using FFL. On correlation of fiberoptic laryngoscopic diagnosis with histopathological examination, the diagnostic accuracy of FFL examination in diagnosing truly benign lesions is 94.9% in our study.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.